Is Pfizer's established drugs' decline in China the ‘canary in the coalmine?’

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 19, 2019 at 12:02 PM.

  1. #1 cafead, Aug 19, 2019 at 12:02 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,255
    Likes Received:
    3
    via Big Pharma has been able to count on China to jack up growth for the last several years, but in the second quarter one drugmaker—Pfizer's Upjohn unit—wasn't so fortunate. Is that an ill omen for the rest of multinational pharma? Yes and no, one analyst figures.

    article source
     
    Quote

Reply to Thread